OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $32,452,000 | -28.3% | 18,868 | -12.0% | 0.00% | – |
| Q3 2015 | $45,249,000 | -61.1% | 21,445 | -8.8% | 0.00% | – |
| Q2 2015 | $116,384,000 | -35.1% | 23,512 | +2.7% | 0.00% | – |
| Q1 2015 | $179,252,000 | +136.6% | 22,893 | +83.1% | 0.00% | – |
| Q4 2014 | $75,750,000 | -75.0% | 12,500 | -82.4% | 0.00% | – |
| Q3 2014 | $303,223,000 | +82.6% | 71,179 | +166.6% | 0.00% | – |
| Q2 2014 | $166,047,000 | -63.1% | 26,694 | -64.3% | 0.00% | – |
| Q1 2014 | $449,439,000 | +6406.1% | 74,707 | +5988.6% | 0.00% | – |
| Q4 2013 | $6,908,000 | -95.6% | 1,227 | -95.3% | 0.00% | – |
| Q3 2013 | $158,418,000 | -20.5% | 25,843 | -24.1% | 0.00% | – |
| Q2 2013 | $199,239,000 | – | 34,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
| Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
| First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
| Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
| Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
| NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
| PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
| Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
| QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |